(Q53575167)

15 May 2018

title

Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase. (English)

1 reference

15 May 2018

author

Johannes Fischer

4

1 reference

15 May 2018

author name string

E Diaz-Blanco

1

1 reference

15 May 2018

I Bruns

2

1 reference

15 May 2018

F Neumann

3

1 reference

15 May 2018

T Graef

5

1 reference

15 May 2018

M Rosskopf

6

1 reference

15 May 2018

B Brors

7

1 reference

15 May 2018

S Pechtel

8

1 reference

15 May 2018

S Bork

9

1 reference

15 May 2018

A Koch

10

1 reference

15 May 2018

A Baer

11

1 reference

15 May 2018

U-P Rohr

12

1 reference

15 May 2018

G Kobbe

13

1 reference

15 May 2018

A von Haeseler

14

1 reference

15 May 2018

N Gattermann

15

1 reference

15 May 2018

R Haas

16

1 reference

15 May 2018

R Kronenwett

17

1 reference

15 May 2018

publication date

25 January 2007

1 reference

15 May 2018

published in

Leukemia

1 reference

15 May 2018

volume

21

1 reference

15 May 2018

issue

3

1 reference

15 May 2018

page(s)

494-504

1 reference

15 May 2018

Chronic myeloid leukaemia: stem cell derived but progenitor cell driven

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

Variance stabilization applied to microarray data calibration and to the quantification of differential expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

Expression of dominant-negative mutant DP-1 blocks cell cycle progression in G1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

The biology of chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Mechanisms underlying abnormal trafficking and expansion of malignant progenitors in CML: BCR/ABL-induced defects in integrin function in CML.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Distinct molecular phenotype of malignant CD34(+) hematopoietic stem and progenitor cells in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Chronic myelogenous leukemia molecular signature.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Gene expression signature of primary imatinib-resistant chronic myeloid leukemia patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Pharmacogenomic analysis of cytogenetic response in chronic myeloid leukemia patients treated with imatinib

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Gene expression profiling of Philadelphia chromosome (Ph)-negative CD34+ hematopoietic stem and progenitor cells of patients with Ph-positive CML in major molecular remission during therapy with imatinib

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Identification of genes involved in imatinib resistance in CML: a gene-expression profiling approach

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Molecular profiling of CD34+ cells identifies low expression of CD7, along with high expression of proteinase 3 or elastase, as predictors of longer survival in patients with CML.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Gene expression changes associated with progression and response in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Gene expression profiling of CD34+ cells identifies a molecular signature of chronic myeloid leukemia blast crisis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow-derived and circulating human CD34+ hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Significance analysis of microarrays applied to the ionizing radiation response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Inhibition of angiogenesis in vitro by alphav integrin-directed antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Prospective isolation of human clonogenic common myeloid progenitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Minimum information about a microarray experiment (MIAME)-toward standards for microarray data

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Consensus guidelines for microarray gene expression analyses in leukemia from three European leukemia networks

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Gene-expression profiling of CD34+ cells from various hematopoietic stem-cell sources reveals functional differences in stem-cell activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

The Bcr-Abl tyrosine kinase activates mitogenic signaling pathways and stimulates G1-to-S phase transition in hematopoietic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Dominant negative MYC blocks transformation by ABL oncogenes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Hematopoietic cytokines, transcription factors and lineage commitment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Impact of BCR/ABL gene expression on the proliferative rate of different subpopulations of haematopoietic cells in chronic myeloid leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Expression of interferon consensus sequence binding protein (ICSBP) is downregulated in Bcr-Abl-induced murine chronic myelogenous leukemia-like disease, and forced coexpression of ICSBP inhibits Bcr-Abl-induced myeloproliferative disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR/ABL and down-regulates bcl-2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

The adapter protein Crkl links Cbl to C3G after integrin ligation and enhances cell migration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Bcr/Abl expression stimulates integrin function in hematopoietic cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Integrin inhibition through Lyn-dependent cross talk from CXCR4 chemokine receptors in normal human CD34+ marrow cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Localization of BCR-ABL to F-actin regulates cell adhesion but does not attenuate CML development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

The hematopoietic stem cell in its place

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Biological effects of stroma-derived factor-1 alpha on normal and CML CD34+ haemopoietic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Immature leukemic CD34+CXCR4+ cells from CML patients have lower integrin-dependent migration and adhesion in response to the chemokine SDF-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

A sustained and pancellular reversal of gamma-globin gene silencing in adult human erythroid precursor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

The activity of guanine exchange factor NET1 is essential for transforming growth factor-beta-mediated stress fiber formation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Characterization of the biochemical and transforming properties of the neuroepithelial transforming protein 1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Activation of RhoA and SAPK/JNK signalling pathways by the RhoA-specific exchange factor mNET1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Differential expression of Hox, Meis1, and Pbx1 genes in primitive cells throughout murine hematopoietic ontogeny

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Persistent transactivation by meis1 replaces hox function in myeloid leukemogenesis models: evidence for co-occupancy of meis1-pbx and hox-pbx complexes on promoters of leukemia-associated genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Intracellular signalling pathways activated by leptin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Expression of the leptin receptor in human leukaemic blast cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Leptin: a promising therapeutic target with pleiotropic action besides body weight regulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

DLC-1, a Rho GTPase-activating protein with tumor suppressor function, is essential for embryonic development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Tissue inhibitor of metalloproteinases-1 signalling pathway leading to erythroid cell survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Identification and molecular characterization of acyl-CoA synthetase in human erythrocytes and erythroid precursors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Transforming growth factor inhibits erythropoiesis by blocking proliferation and accelerating differentiation of erythroid progenitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404549

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2404549

1 reference

15 May 2018

1 reference

15 May 2018